Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.6%

381 terminated/withdrawn out of 2603 trials

Success Rate

81.7%

-4.8% vs industry average

Late-Stage Pipeline

10%

267 trials in Phase 3/4

Results Transparency

43%

726 of 1705 completed trials have results

Key Signals

251 recruiting726 with results240 terminated141 withdrawn

Enrollment Performance

Analytics

N/A

1296(63.5%)

Phase 2

265(13.0%)

Phase 1

194(9.5%)

Phase 4

194(9.5%)

Phase 3

73(3.6%)

Early Phase 1

20(1.0%)

2042Total

N/A(1296)

Phase 2(265)

Phase 1(194)

Phase 4(194)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2603)

Showing 20 of 2603 trials

NCT04667585Not ApplicableActive Not Recruiting

Radiotherapy Dose De-escalation in HPV-Associated Cancers of the Oropharynx

Role: lead

NCT06127524Phase 2Active Not Recruiting

Skin Change Actions by Nursing

Role: collaborator

NCT07021040Not ApplicableRecruiting

Olfactory Biopsies

Role: lead

NCT03414645Phase 1Completed

Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease

Role: collaborator

NCT05241275Phase 2Active Not Recruiting

Xenon MRI and Progressive ILD

Role: lead

NCT07519317Not ApplicableNot Yet Recruiting

Dosing and Deployment Trial: A Home-based Optokinetic Treatment

Role: lead

NCT06529120Not ApplicableActive Not Recruiting

Adaptation and Pilot Testing of a Mindfulness-Based Insomnia and Symptom Management Intervention for Women With Breast Cancer Receiving Treatment in Rural Medically Underserved Areas

Role: lead

NCT07633145Not ApplicableNot Yet Recruiting

Lifestyle Intervention In CKD

Role: lead

NCT06328114Phase 2Enrolling By Invitation

Accelerating TMS for Cervical Dystonia

Role: lead

NCT06785636Phase 1Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Role: collaborator

NCT04572256Early Phase 1Recruiting

MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)

Role: collaborator

NCT06909565Phase 4Recruiting

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Role: lead

NCT05710744Not ApplicableNot Yet Recruiting

Mitigating Racial Disparities in Shared Decision Making in the Intensive Care Unit

Role: lead

NCT07634419Not ApplicableNot Yet Recruiting

Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress: the Lift RCT

Role: lead

NCT03473795Active Not Recruiting

Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes

Role: collaborator

NCT06249386Not ApplicableCompleted

Adapting and Piloting Behavioral Activation for Veterans With Alcohol Use Disorder and Posttraumatic Stress Disorder